Myopia: An ounce of prevention is worth a pound of cure
Purpose Myopia severity has a profound impact on visual impairment in later life. A patient's final level of myopia may be lowered by myopia control, but also by delaying onset. Here, we evaluate the influence of the age of onset on the final recorded level of myopia. Methods Data were extracte...
Saved in:
| Published in: | Ophthalmic & physiological optics Vol. 43; no. 1; pp. 116 - 121 |
|---|---|
| Main Authors: | , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
Wiley Subscription Services, Inc
01.01.2023
|
| Subjects: | |
| ISSN: | 0275-5408, 1475-1313, 1475-1313 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Purpose
Myopia severity has a profound impact on visual impairment in later life. A patient's final level of myopia may be lowered by myopia control, but also by delaying onset. Here, we evaluate the influence of the age of onset on the final recorded level of myopia.
Methods
Data were extracted from: (1) Three prospective cohort studies of myopia progression in East Asia and the United States where the final recorded level of myopia is presented as a function of the established age of onset. (2) Four retrospective studies of myopia progression in Finland, India, the Netherlands and China and two cross‐sectional studies in Argentina and the UK where the age of onset was based on self‐report of age at first spectacle prescription. (3) A cohort study of Finnish subjects originally recruited for a clinical trial and followed into adulthood. Subjects were divided into five groups according to age at recruitment that was used as a surrogate for the age of onset.
Results
Final recorded level of myopia was plotted as a function of age of onset for all studies. Among the three East Asian studies, the slopes are between 0.68 and 0.97 D/year, meaning that each later year of onset is associated with between 0.68 and 0.97 less myopia at the final recorded refraction. For six of the seven non‐East Asian studies, the slopes are substantially flatter, with slopes between 0.23 and 0.50 D/year. By contrast, the slope for the Finnish study was 0.87 D/year. Increasing age of final recorded refraction tended to be associated with higher levels of myopia.
Conclusion
Among East Asians, delaying the onset of myopia by 1 year has the potential to lower the final myopia level by 0.75 D or more—equivalent to 2–3 years of myopia control with existing modalities. The benefit is lower, but meaningful, among non‐East Asians. |
|---|---|
| AbstractList | Myopia severity has a profound impact on visual impairment in later life. A patient's final level of myopia may be lowered by myopia control, but also by delaying onset. Here, we evaluate the influence of the age of onset on the final recorded level of myopia.
Data were extracted from: (1) Three prospective cohort studies of myopia progression in East Asia and the United States where the final recorded level of myopia is presented as a function of the established age of onset. (2) Four retrospective studies of myopia progression in Finland, India, the Netherlands and China and two cross-sectional studies in Argentina and the UK where the age of onset was based on self-report of age at first spectacle prescription. (3) A cohort study of Finnish subjects originally recruited for a clinical trial and followed into adulthood. Subjects were divided into five groups according to age at recruitment that was used as a surrogate for the age of onset.
Final recorded level of myopia was plotted as a function of age of onset for all studies. Among the three East Asian studies, the slopes are between 0.68 and 0.97 D/year, meaning that each later year of onset is associated with between 0.68 and 0.97 less myopia at the final recorded refraction. For six of the seven non-East Asian studies, the slopes are substantially flatter, with slopes between 0.23 and 0.50 D/year. By contrast, the slope for the Finnish study was 0.87 D/year. Increasing age of final recorded refraction tended to be associated with higher levels of myopia.
Among East Asians, delaying the onset of myopia by 1 year has the potential to lower the final myopia level by 0.75 D or more-equivalent to 2-3 years of myopia control with existing modalities. The benefit is lower, but meaningful, among non-East Asians. Myopia severity has a profound impact on visual impairment in later life. A patient's final level of myopia may be lowered by myopia control, but also by delaying onset. Here, we evaluate the influence of the age of onset on the final recorded level of myopia.PURPOSEMyopia severity has a profound impact on visual impairment in later life. A patient's final level of myopia may be lowered by myopia control, but also by delaying onset. Here, we evaluate the influence of the age of onset on the final recorded level of myopia.Data were extracted from: (1) Three prospective cohort studies of myopia progression in East Asia and the United States where the final recorded level of myopia is presented as a function of the established age of onset. (2) Four retrospective studies of myopia progression in Finland, India, the Netherlands and China and two cross-sectional studies in Argentina and the UK where the age of onset was based on self-report of age at first spectacle prescription. (3) A cohort study of Finnish subjects originally recruited for a clinical trial and followed into adulthood. Subjects were divided into five groups according to age at recruitment that was used as a surrogate for the age of onset.METHODSData were extracted from: (1) Three prospective cohort studies of myopia progression in East Asia and the United States where the final recorded level of myopia is presented as a function of the established age of onset. (2) Four retrospective studies of myopia progression in Finland, India, the Netherlands and China and two cross-sectional studies in Argentina and the UK where the age of onset was based on self-report of age at first spectacle prescription. (3) A cohort study of Finnish subjects originally recruited for a clinical trial and followed into adulthood. Subjects were divided into five groups according to age at recruitment that was used as a surrogate for the age of onset.Final recorded level of myopia was plotted as a function of age of onset for all studies. Among the three East Asian studies, the slopes are between 0.68 and 0.97 D/year, meaning that each later year of onset is associated with between 0.68 and 0.97 less myopia at the final recorded refraction. For six of the seven non-East Asian studies, the slopes are substantially flatter, with slopes between 0.23 and 0.50 D/year. By contrast, the slope for the Finnish study was 0.87 D/year. Increasing age of final recorded refraction tended to be associated with higher levels of myopia.RESULTSFinal recorded level of myopia was plotted as a function of age of onset for all studies. Among the three East Asian studies, the slopes are between 0.68 and 0.97 D/year, meaning that each later year of onset is associated with between 0.68 and 0.97 less myopia at the final recorded refraction. For six of the seven non-East Asian studies, the slopes are substantially flatter, with slopes between 0.23 and 0.50 D/year. By contrast, the slope for the Finnish study was 0.87 D/year. Increasing age of final recorded refraction tended to be associated with higher levels of myopia.Among East Asians, delaying the onset of myopia by 1 year has the potential to lower the final myopia level by 0.75 D or more-equivalent to 2-3 years of myopia control with existing modalities. The benefit is lower, but meaningful, among non-East Asians.CONCLUSIONAmong East Asians, delaying the onset of myopia by 1 year has the potential to lower the final myopia level by 0.75 D or more-equivalent to 2-3 years of myopia control with existing modalities. The benefit is lower, but meaningful, among non-East Asians. PurposeMyopia severity has a profound impact on visual impairment in later life. A patient's final level of myopia may be lowered by myopia control, but also by delaying onset. Here, we evaluate the influence of the age of onset on the final recorded level of myopia.MethodsData were extracted from: (1) Three prospective cohort studies of myopia progression in East Asia and the United States where the final recorded level of myopia is presented as a function of the established age of onset. (2) Four retrospective studies of myopia progression in Finland, India, the Netherlands and China and two cross‐sectional studies in Argentina and the UK where the age of onset was based on self‐report of age at first spectacle prescription. (3) A cohort study of Finnish subjects originally recruited for a clinical trial and followed into adulthood. Subjects were divided into five groups according to age at recruitment that was used as a surrogate for the age of onset.ResultsFinal recorded level of myopia was plotted as a function of age of onset for all studies. Among the three East Asian studies, the slopes are between 0.68 and 0.97 D/year, meaning that each later year of onset is associated with between 0.68 and 0.97 less myopia at the final recorded refraction. For six of the seven non‐East Asian studies, the slopes are substantially flatter, with slopes between 0.23 and 0.50 D/year. By contrast, the slope for the Finnish study was 0.87 D/year. Increasing age of final recorded refraction tended to be associated with higher levels of myopia.ConclusionAmong East Asians, delaying the onset of myopia by 1 year has the potential to lower the final myopia level by 0.75 D or more—equivalent to 2–3 years of myopia control with existing modalities. The benefit is lower, but meaningful, among non‐East Asians. Purpose Myopia severity has a profound impact on visual impairment in later life. A patient's final level of myopia may be lowered by myopia control, but also by delaying onset. Here, we evaluate the influence of the age of onset on the final recorded level of myopia. Methods Data were extracted from: (1) Three prospective cohort studies of myopia progression in East Asia and the United States where the final recorded level of myopia is presented as a function of the established age of onset. (2) Four retrospective studies of myopia progression in Finland, India, the Netherlands and China and two cross‐sectional studies in Argentina and the UK where the age of onset was based on self‐report of age at first spectacle prescription. (3) A cohort study of Finnish subjects originally recruited for a clinical trial and followed into adulthood. Subjects were divided into five groups according to age at recruitment that was used as a surrogate for the age of onset. Results Final recorded level of myopia was plotted as a function of age of onset for all studies. Among the three East Asian studies, the slopes are between 0.68 and 0.97 D/year, meaning that each later year of onset is associated with between 0.68 and 0.97 less myopia at the final recorded refraction. For six of the seven non‐East Asian studies, the slopes are substantially flatter, with slopes between 0.23 and 0.50 D/year. By contrast, the slope for the Finnish study was 0.87 D/year. Increasing age of final recorded refraction tended to be associated with higher levels of myopia. Conclusion Among East Asians, delaying the onset of myopia by 1 year has the potential to lower the final myopia level by 0.75 D or more—equivalent to 2–3 years of myopia control with existing modalities. The benefit is lower, but meaningful, among non‐East Asians. |
| Author | Bullimore, Mark A. Brennan, Noel A. |
| Author_xml | – sequence: 1 givenname: Mark A. orcidid: 0000-0002-6315-3720 surname: Bullimore fullname: Bullimore, Mark A. email: bullers2020@gmail.com organization: University of Houston – sequence: 2 givenname: Noel A. orcidid: 0000-0003-4635-6435 surname: Brennan fullname: Brennan, Noel A. organization: Johnson & Johnson Vision |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36197452$$D View this record in MEDLINE/PubMed |
| BookMark | eNp90M9LwzAUB_AgE_dDD_4DUvCih255Sdok3sbwF0zmQc8lzVLs6JqatI7992ZuehD0XfLgfd4jfIeoV9vaIHQOeAyhJraxY6A4EUdoAIwnMVCgPTTAJPQJw6KPht6vMMacc3GC-jQFyVlCBog_bW1TqptoWke2q7WJbBE1znyYui1tHZU-2ljXvkUqasJ8uRvrzplTdFyoypuzwztCr3e3L7OHeL64f5xN57FmIEUMglPNaZrmidIsJykAzkkuiAS95AUtAHSOQRZFqohkuSSaUE5UWhDBgqEjdLW_2zj73hnfZuvSa1NVqja28xnhBFKGcZIGevmLrmzn6vC7oBiXiaRCBnVxUF2-NsusceVauW32HUkA13ugnfXemeKHAM52cWch7uwr7mAnv6wuW7ULrnWqrP7b2JSV2f59Ols8L_YbnxetjQg |
| CitedBy_id | crossref_primary_10_1167_iovs_66_7_7 crossref_primary_10_1167_iovs_66_7_6 crossref_primary_10_1111_opo_13416 crossref_primary_10_1038_s41433_023_02722_6 crossref_primary_10_1016_j_ophtha_2025_08_001 crossref_primary_10_1111_opo_13240 crossref_primary_10_1111_opo_13099 crossref_primary_10_1167_iovs_66_12_27 crossref_primary_10_1167_iovs_66_12_39 crossref_primary_10_3390_children11020139 crossref_primary_10_1111_opo_13563 crossref_primary_10_1038_s41598_023_42108_y crossref_primary_10_22599_bioj_341 crossref_primary_10_1097_ICL_0000000000001191 crossref_primary_10_1080_08164622_2025_2502527 crossref_primary_10_3390_children11121446 crossref_primary_10_1016_j_ebiom_2023_104551 crossref_primary_10_1097_OPX_0000000000002167 crossref_primary_10_1055_a_2307_0363 |
| Cites_doi | 10.1007/s10654-015-0010-0 10.1136/bjophthalmol-2018-313739 10.1167/iovs.02-0816 10.1167/iovs.61.4.49 10.1097/OPX.0000000000001410 10.1371/journal.pone.0241759 10.1001/jamaophthalmol.2017.6638 10.1167/iovs.13-12403 10.1016/j.ophtha.2018.05.029 10.1111/opo.12686 10.1016/j.ophtha.2021.10.002 10.1097/OPX.0000000000001367 10.1001/jamaophthalmol.2020.3451 10.1016/j.clae.2020.03.018 10.1111/aos.14545 10.1080/09286580802624442 10.1001/archophthalmol.2009.303 10.1001/jamaophthalmol.2016.4009 10.1111/opo.12042 10.3928/0191-3913-19850301-10 10.1016/j.ophtha.2021.04.032 10.1016/j.preteyeres.2017.09.004 10.1016/j.ophtha.2007.12.019 10.1016/j.ophtha.2012.11.009 10.1111/aos.13964 10.1167/iovs.62.10.36 10.1016/j.preteyeres.2020.100923 10.1097/OPX.0b013e3182357f79 10.1136/bjophthalmol-2020-316234 10.1167/iovs.06-1118 10.1111/opo.12305 |
| ContentType | Journal Article |
| Copyright | 2022 College of Optometrists. Copyright © 2023 The Authors Ophthalmic and Physiological Optics © 2023 The College of Optometrists |
| Copyright_xml | – notice: 2022 College of Optometrists. – notice: Copyright © 2023 The Authors Ophthalmic and Physiological Optics © 2023 The College of Optometrists |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QG 7T5 7TK H94 7X8 |
| DOI | 10.1111/opo.13058 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Animal Behavior Abstracts Immunology Abstracts Neurosciences Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Immunology Abstracts Neurosciences Abstracts Animal Behavior Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic AIDS and Cancer Research Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Physics |
| EISSN | 1475-1313 |
| EndPage | 121 |
| ExternalDocumentID | 36197452 10_1111_opo_13058 OPO13058 |
| Genre | article Journal Article |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GroupedDBID | --- --K .3N .GA .Y3 05W 0R~ 10A 123 1B1 1OB 1OC 1~5 29N 31~ 33P 36B 3SF 4.4 4G. 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 7-5 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEDT AAESR AAEVG AAHHS AAHQN AAIPD AALRI AAMNL AANHP AANLZ AAONW AAQFI AAQXK AASGY AAXRX AAXUO AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABMAC ABPVW ABQWH ABWVN ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACNCT ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADMUD ADNMO ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHEFC AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO EAD EAP EBC EBD EBS EJD EMB EMK EMOBN EPS ESX EX3 F00 F01 F04 F5P FDB FEDTE FGOYB FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M41 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NQ- O66 O9- OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K R2- RIWAO RJQFR ROL RPZ RX1 SAMSI SEW SSZ SUPJJ SV3 TEORI TUS UB1 UHS V8K W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH YUY ZZTAW ~IA ~WT 9DU AAMMB AAYXX ACVFH ADCNI AEFGJ AEUPX AEYWJ AFPUW AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY AIQQE CITATION O8X CGR CUY CVF ECM EIF NPM 7QG 7T5 7TK H94 7X8 |
| ID | FETCH-LOGICAL-c4198-1873c7366b5ac4b26110b2b8291cd7f3f11cb019ff6a294b92c2372a6f28491c3 |
| IEDL.DBID | DRFUL |
| ISICitedReferencesCount | 19 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000863897100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0275-5408 1475-1313 |
| IngestDate | Thu Oct 02 05:03:58 EDT 2025 Wed Aug 13 05:53:49 EDT 2025 Wed Feb 19 02:25:09 EST 2025 Sat Nov 29 03:36:47 EST 2025 Tue Nov 18 22:18:53 EST 2025 Wed Jan 22 16:22:24 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | myopia progression prevention age of onset |
| Language | English |
| License | 2022 College of Optometrists. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4198-1873c7366b5ac4b26110b2b8291cd7f3f11cb019ff6a294b92c2372a6f28491c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-6315-3720 0000-0003-4635-6435 |
| PMID | 36197452 |
| PQID | 2747959389 |
| PQPubID | 2045120 |
| PageCount | 6 |
| ParticipantIDs | proquest_miscellaneous_2721640056 proquest_journals_2747959389 pubmed_primary_36197452 crossref_primary_10_1111_opo_13058 crossref_citationtrail_10_1111_opo_13058 wiley_primary_10_1111_opo_13058_OPO13058 |
| PublicationCentury | 2000 |
| PublicationDate | January 2023 |
| PublicationDateYYYYMMDD | 2023-01-01 |
| PublicationDate_xml | – month: 01 year: 2023 text: January 2023 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | Ophthalmic & physiological optics |
| PublicationTitleAlternate | Ophthalmic Physiol Opt |
| PublicationYear | 2023 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2019; 97 2019; 96 2020; 40 2020; 61 2021; 128 2021; 106 2015; 30 2000; 41 2021; 129 2020; 104 2019; 126 2020; 15 2022; 63 2018; 62 2021; 100 2013; 120 1985; 22 2016; 36 2021; 99 2013; 33 2013; 54 2018; 136 2020; 138 2016; 134 2008; 115 2020; 43 2021; 83 2012; 89 2021; 62 2009; 16 2009; 127 2003; 44 2007; 48 Shamp W (e_1_2_9_26_1) 2022; 63 e_1_2_9_30_1 e_1_2_9_31_1 e_1_2_9_11_1 e_1_2_9_34_1 e_1_2_9_10_1 e_1_2_9_35_1 e_1_2_9_13_1 e_1_2_9_32_1 e_1_2_9_12_1 e_1_2_9_33_1 e_1_2_9_14_1 e_1_2_9_17_1 e_1_2_9_36_1 e_1_2_9_16_1 e_1_2_9_19_1 e_1_2_9_18_1 e_1_2_9_22_1 e_1_2_9_21_1 e_1_2_9_24_1 e_1_2_9_23_1 e_1_2_9_8_1 e_1_2_9_7_1 e_1_2_9_6_1 e_1_2_9_5_1 e_1_2_9_4_1 e_1_2_9_3_1 e_1_2_9_2_1 Qin Z (e_1_2_9_15_1) 2021; 100 Mutti DO (e_1_2_9_20_1) 2000; 41 e_1_2_9_9_1 Bao J (e_1_2_9_25_1) 2021; 106 e_1_2_9_28_1 e_1_2_9_27_1 e_1_2_9_29_1 |
| References_xml | – volume: 128 start-page: 1561 year: 2021 end-page: 79 article-title: The risks and benefits of myopia control publication-title: Ophthalmology – volume: 129 start-page: 308 year: 2021 end-page: 21 article-title: Three‐year clinical trial of low‐concentration atropine for myopia progression (LAMP) study: continued versus washout. Phase 3 report publication-title: Ophthalmology – volume: 115 start-page: 1279 year: 2008 end-page: 85 article-title: Outdoor activity reduces the prevalence of myopia in children publication-title: Ophthalmology – volume: 97 start-page: 510 year: 2019 end-page: 8 article-title: Risk factors for high myopia: a 22‐year follow‐up study from childhood to adulthood publication-title: Acta Ophthalmol – volume: 127 start-page: 1632 year: 2009 end-page: 9 article-title: Increased prevalence of myopia in the United States between 1971‐1972 and 1999‐2004 publication-title: Arch Ophthalmol – volume: 96 start-page: 556 year: 2019 end-page: 67 article-title: A 3‐year randomized clinical trial of MiSight lenses for myopia control publication-title: Optom Vis Sci – volume: 96 start-page: 463 year: 2019 end-page: 5 article-title: Myopia control: why each diopter matters publication-title: Optom Vis Sci – volume: 62 start-page: 134 year: 2018 end-page: 49 article-title: The epidemics of myopia: aetiology and prevention publication-title: Prog Retin Eye Res – volume: 43 start-page: 322 year: 2020 end-page: 32 article-title: Overnight orthokeratology publication-title: Cont Lens Anterior Eye – volume: 106 start-page: 1171 year: 2021 end-page: 6 article-title: One‐year myopia control efficacy of spectacle lenses with aspherical lenslets publication-title: Br J Ophthalmol – volume: 61 start-page: 49 year: 2020 article-title: The complications of myopia: a review and meta‐analysis publication-title: Invest Ophthalmol Vis Sci – volume: 15 year: 2020 article-title: Myopia progression varies with age and severity of myopia publication-title: PLoS One – volume: 44 start-page: 1492 year: 2003 end-page: 500 article-title: A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children publication-title: Invest Ophthalmol Vis Sci – volume: 83 year: 2021 article-title: Efficacy in myopia control publication-title: Prog Retin Eye Res – volume: 89 start-page: 27 year: 2012 end-page: 32 article-title: Myopia progression rates in urban children wearing single‐vision spectacles publication-title: Optom Vis Sci – volume: 33 start-page: 339 year: 2013 end-page: 45 article-title: Age of myopia onset in a British population‐based twin cohort publication-title: Ophthalmic Physiol Opt – volume: 22 start-page: 71 year: 1985 end-page: 5 article-title: Predicting of myopia progression in school children publication-title: J Pediatr Ophthalmol Strabismus – volume: 138 start-page: 1129 year: 2020 end-page: 34 article-title: Association of age at myopia onset with risk of high myopia in adulthood in a 12‐year follow‐up of a Chinese cohort publication-title: JAMA Ophthalmol – volume: 54 start-page: 7871 year: 2013 end-page: 84 article-title: Myopia stabilization and associated factors among participants in the correction of myopia evaluation trial (COMET) publication-title: Invest Ophthalmol Vis Sci – volume: 99 start-page: 171 year: 2021 end-page: 80 article-title: Comparison of myopic progression in Finnish and Singaporean children publication-title: Acta Ophthalmol – volume: 100 start-page: e950 year: 2021 end-page: 6 article-title: Myopia progression and stabilization in school‐aged children with single‐vision lenses publication-title: Acta Ophthalmol – volume: 106 start-page: 820 year: 2021 end-page: 4 article-title: Myopia progression from wearing first glasses to adult age: the DREAM study publication-title: Br J Ophthalmol – volume: 63 start-page: 257 year: 2022 article-title: Influence of age and race on axial elongation In myopic children publication-title: Optom Vis Sci – volume: 30 start-page: 305 year: 2015 end-page: 15 article-title: Prevalence of refractive error in Europe: the European eye epidemiology (E[3]) consortium publication-title: Eur J Epidemiol – volume: 62 start-page: 36 year: 2021 article-title: Myopia progression as a function of sex, age, and ethnicity publication-title: Invest Ophthalmol Vis Sci – volume: 48 start-page: 3524 year: 2007 end-page: 32 article-title: Parental history of myopia, sports and outdoor activities, and future myopia publication-title: Invest Ophthalmol Vis Sci – volume: 136 start-page: 303 year: 2018 article-title: Low‐dose atropine for myopia control: considering all the data publication-title: JAMA Ophthalmol – volume: 40 start-page: 254 year: 2020 end-page: 70 article-title: Myopia control 2020: where are we and where are we heading? publication-title: Ophthalmic Physiol Opt – volume: 134 start-page: 1355 year: 2016 end-page: 63 article-title: Association of axial length with risk of uncorrectable visual impairment for Europeans with myopia publication-title: JAMA Ophthalmol – volume: 126 start-page: 113 year: 2019 end-page: 24 article-title: Low‐concentration atropine for myopia progression (LAMP) study: a randomized, double‐blinded, placebo‐controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control publication-title: Ophthalmology – volume: 16 start-page: 84 year: 2009 end-page: 9 article-title: Age of first distance prescription and final myopic refractive error publication-title: Ophthalmic Epidemiol – volume: 104 start-page: 363 year: 2020 end-page: 8 article-title: Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: a 2‐year randomised clinical trial publication-title: Br J Ophthalmol – volume: 120 start-page: 1080 year: 2013 end-page: 5 article-title: Outdoor activity during class recess reduces myopia onset and progression in school children publication-title: Ophthalmology – volume: 41 start-page: 2103 year: 2000 end-page: 7 article-title: Age‐related decreases in the prevalence of myopia: longitudinal change or cohort effect? publication-title: Invest Ophthalmol Vis Sci – volume: 36 start-page: 388 year: 2016 end-page: 94 article-title: Age of onset of myopia predicts risk of high myopia in later childhood in myopic Singapore children publication-title: Ophthalmic Physiol Opt – ident: e_1_2_9_2_1 doi: 10.1007/s10654-015-0010-0 – ident: e_1_2_9_23_1 doi: 10.1136/bjophthalmol-2018-313739 – volume: 63 start-page: 257 year: 2022 ident: e_1_2_9_26_1 article-title: Influence of age and race on axial elongation In myopic children publication-title: Optom Vis Sci – ident: e_1_2_9_28_1 doi: 10.1167/iovs.02-0816 – ident: e_1_2_9_3_1 doi: 10.1167/iovs.61.4.49 – ident: e_1_2_9_22_1 doi: 10.1097/OPX.0000000000001410 – ident: e_1_2_9_13_1 doi: 10.1371/journal.pone.0241759 – ident: e_1_2_9_31_1 doi: 10.1001/jamaophthalmol.2017.6638 – ident: e_1_2_9_18_1 doi: 10.1167/iovs.13-12403 – ident: e_1_2_9_32_1 doi: 10.1016/j.ophtha.2018.05.029 – ident: e_1_2_9_5_1 doi: 10.1111/opo.12686 – ident: e_1_2_9_33_1 doi: 10.1016/j.ophtha.2021.10.002 – ident: e_1_2_9_30_1 doi: 10.1097/OPX.0000000000001367 – ident: e_1_2_9_11_1 doi: 10.1001/jamaophthalmol.2020.3451 – ident: e_1_2_9_24_1 doi: 10.1016/j.clae.2020.03.018 – ident: e_1_2_9_27_1 doi: 10.1111/aos.14545 – ident: e_1_2_9_7_1 doi: 10.1080/09286580802624442 – volume: 100 start-page: e950 year: 2021 ident: e_1_2_9_15_1 article-title: Myopia progression and stabilization in school‐aged children with single‐vision lenses publication-title: Acta Ophthalmol – ident: e_1_2_9_19_1 doi: 10.1001/archophthalmol.2009.303 – ident: e_1_2_9_29_1 doi: 10.1001/jamaophthalmol.2016.4009 – ident: e_1_2_9_8_1 doi: 10.1111/opo.12042 – ident: e_1_2_9_6_1 doi: 10.3928/0191-3913-19850301-10 – ident: e_1_2_9_4_1 doi: 10.1016/j.ophtha.2021.04.032 – ident: e_1_2_9_10_1 doi: 10.1016/j.preteyeres.2017.09.004 – ident: e_1_2_9_35_1 doi: 10.1016/j.ophtha.2007.12.019 – ident: e_1_2_9_36_1 doi: 10.1016/j.ophtha.2012.11.009 – ident: e_1_2_9_16_1 doi: 10.1111/aos.13964 – ident: e_1_2_9_12_1 doi: 10.1167/iovs.62.10.36 – ident: e_1_2_9_21_1 doi: 10.1016/j.preteyeres.2020.100923 – volume: 106 start-page: 1171 year: 2021 ident: e_1_2_9_25_1 article-title: One‐year myopia control efficacy of spectacle lenses with aspherical lenslets publication-title: Br J Ophthalmol – volume: 41 start-page: 2103 year: 2000 ident: e_1_2_9_20_1 article-title: Age‐related decreases in the prevalence of myopia: longitudinal change or cohort effect? publication-title: Invest Ophthalmol Vis Sci – ident: e_1_2_9_17_1 doi: 10.1097/OPX.0b013e3182357f79 – ident: e_1_2_9_14_1 doi: 10.1136/bjophthalmol-2020-316234 – ident: e_1_2_9_34_1 doi: 10.1167/iovs.06-1118 – ident: e_1_2_9_9_1 doi: 10.1111/opo.12305 |
| SSID | ssj0007778 |
| Score | 2.426223 |
| Snippet | Purpose
Myopia severity has a profound impact on visual impairment in later life. A patient's final level of myopia may be lowered by myopia control, but also... Myopia severity has a profound impact on visual impairment in later life. A patient's final level of myopia may be lowered by myopia control, but also by... PurposeMyopia severity has a profound impact on visual impairment in later life. A patient's final level of myopia may be lowered by myopia control, but also... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 116 |
| SubjectTerms | Adult Age age of onset Asian people Asian studies China Cohort Studies Cross-Sectional Studies Humans Myopia prevention progression Prospective Studies Refraction Retrospective Studies |
| Title | Myopia: An ounce of prevention is worth a pound of cure |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fopo.13058 https://www.ncbi.nlm.nih.gov/pubmed/36197452 https://www.proquest.com/docview/2747959389 https://www.proquest.com/docview/2721640056 |
| Volume | 43 |
| WOSCitedRecordID | wos000863897100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Journals customDbUrl: eissn: 1475-1313 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007778 issn: 0275-5408 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFD7ovOCLl3mblxHFB18Ka9I0qT6JOnxwF8TB3kqSNjCQtqyb4L83abviUEEQ-lDIKQk5l5wvSb8DcKVNys-kDBwtle94lHUc4SnsCBmYB_OO1AW7_jPr9_l4HAxX4HbxL0zJD1FvuFnPKOK1dXAh8y9OnmapLWVM-SqsYWO3tAFrDy_d0XMdiBkrAzFm1J7_84pYyF7kqT9eXo6-5ZjLKWux5nR3_jXaXdiuUk10V9rGHqzESRM2e9VhehM2itufKt8H1vtIs4m4QXcJMt6vYpRqlFXkTmmCJjkqrhIigTJbhsk2q_k0PoBR9_H1_smpKio4ynMDAxc5I4oR35dUKE8a9OR2JJYcB66KmCbadZU0SZ_WvsCBZ5SlMGFY-NqsYkaGHEIjSZP4GFAkCA44jSRV1GOKSB5FWBLuGYwTceK24HoxsaGq6MZt1Yu3cAE7zJSExZS04LIWzUqOjZ-EzhbaCSs3y0MLqS2zMg9acFE3Gwexpx4iidO5lcEGElrK0xYclVqteyEGPjKPYjPYQnm_dx8OhoPi5eTvoqewZYvTlxs2Z9CYTefxOayr99kkn7ZhlY15u7LZT4Yu6oE |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9swED_S776sWz_TpZtW-tAXQyzJllz6UraFjOWL0kLfjCRbECi2SZpC__uebMcstIPBwA8GnZHQ3Un3k86_A7iwGPILrSPPahN6PBBdT3FDPaUjfKjsaluy6w_EaCQfHqJJC66X_8JU_BDNgZvzjHK9dg7uDqT_8PK8yF0t40CuwQZHM0L73vhx27sfNCuxENVKTEXgEgBkzSzkMnmaj1f3ozdB5mrMWm46vb3_G-5H-FAHm-Smso5P0Eqzfdge1tfp-7BV5n-a-QGI4UteTNUVuckI-r9JSW5JUdM75RmZzkmZTEgUKVwhJtdsFrP0EO57P---9726poJnuB8hYJSCGcHCUAfKcI34ye9qqiWNfJMIy6zvG41hn7WhohFHdRnKBFWhxX0MZdgRrGd5lp4ASRSjkQwSHZiAC8O0TBKqmeSIchLJ_DZcLmc2NjXhuKt78RgvgQdOSVxOSRvOG9GiYtl4T6izVE9cO9o8dqDacSvLqA3fmmZ0EXfvobI0XzgZiqDQkZ624bhSa9MLQwApeEBxsKX2_t59PJ6My5fTfxf9Cjv9u-EgHvwa_f4Mu65UfXV804H1p9kiPYNN8_w0nc--1Kb7Chc87Yk |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS8MwED_mpuKL3x_TqVF88KWwJmmTii_iHIrbHKKwt5KkDQykLZsT_O9N2q4oKghCHwq5knCXS-6XXH8HcKZNyM-kDBwtle9Qj7UdQRV2hAzMg3lb6pxdv8cGAz4aBcMaXM7_hSn4IaoDN-sZ-XptHTzOIv3Jy9MstbWMPb4ADWqLyNSh0XnsPveqlZixYiXGzLMJALxkFrKZPNXHX_ejb0Hm15g133S6a_8b7jqslsEmuipmxwbU4mQTlvvldfomLOX5n2q6Baz_nmZjcYGuEmT8X8Uo1Sgr6Z3SBI2nKE8mRAJlthCTbVazSbwNz92bp-tbp6yp4CjqBgYwckYUI74vPaGoNPjJbUssOQ5cFTFNtOsqacI-rX2BA2rMpTBhWPja7GNGhuxAPUmTeA9QJAgOuBdJT3mUKSJ5FGFJODUoJ-LEbcL5XLOhKgnHbd2Ll3AOPIxKwlwlTTitRLOCZeMnodbcPGHpaNPQgmrLrcyDJpxUzcZF7L2HSOJ0ZmWwAYWW9LQJu4VZq16IAZCMetgMNrfe792HD8OH_GX_76LHsDzsdMPe3eD-AFZspfri9KYF9dfJLD6ERfX2Op5OjsqZ-wG8K-0E |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Myopia%3A+An+ounce+of+prevention+is+worth+a+pound+of+cure&rft.jtitle=Ophthalmic+%26+physiological+optics&rft.au=Bullimore%2C+Mark+A.&rft.au=Brennan%2C+Noel+A.&rft.date=2023-01-01&rft.issn=0275-5408&rft.eissn=1475-1313&rft.volume=43&rft.issue=1&rft.spage=116&rft.epage=121&rft_id=info:doi/10.1111%2Fopo.13058&rft.externalDBID=10.1111%252Fopo.13058&rft.externalDocID=OPO13058 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0275-5408&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0275-5408&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0275-5408&client=summon |